• A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients
• A systematic review and meta-analysis informing the role of adjuvant radiotherapy (RT) in Grade 2 and 3 oligodendroglioma
• Accurate and rapid molecular subgrouping of high-grade glioma via deep learning-assisted label-free fiber-optic Raman spectroscopy
• Approach to a cerebral hernia caused by an intratumoral hemorrhage of a cystic oligodendroglioma: a case report
• Association Between Pretreatment ¹¹C-Methionine Positron Emission Tomography Metrics, Histology, and Prognosis in 125 Newly Diagnosed Patients with Adult-Type Diffuse Glioma Based on the World Health Organization 2021Classification
• Association between pretreatment 11C-methionine PET metrics, histology, and prognosis in 125 newly diagnosed adult diffuse glioma patients based on the WHO 2021 classification
• Association of Clinical, Tumor, and Treatment Characteristics With Seizure Control in Patients With <em>IDH1/2</em>-Mutant Lower-Grade Glioma
• Awake surgery for a deaf patient using sign language: A case report
• Canine glioma in the first year of life: 5 cases
• Case report: Magnetic resonance imaging features with postoperative improvement of atypical cervical glioma characterized by predominant extramedullary distribution in a dog
• Case report: when art is faced with brain surgery: acute change in creative style in a painter after glioma resection
• Cerebellar mass in a 31-year-old woman
• Chromothripsis is rare in IDH-mutant gliomas compared to IDH-wild-type glioblastomas whereas whole-genome duplication is equally frequent in both tumor types
• Clinical and imaging characteristics of supratentorial glioma with IDH2 mutation
• Clinical and imaging characteristics of supratentorial slioma with IDH2 mutation
• Clinical applicability of signal heterogeneity and tumor border assessment on T2-weighted MR images to distinguish astrocytic from oligodendroglial origin of gliomas
• Clinical roles of <em>EGFR</em> amplification in diffuse gliomas: a real-world study using the 2021 WHO classification of CNS tumors
• Construction and Validation of Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Patients with Primary Anaplastic Oligodendroglioma
• Contemporary Prognostic Signatures and Refined Risk Stratification of Gliomas: An Analysis of 4,400 Tumors
• Correlation of ADC values of adult brain tumors with the diagnosis and pathological grade: A cross-sectional multicenter study
• Deep learning-based IDH1 gene mutation prediction using histopathological imaging and clinical data
• Diagnostic and Therapeutic Challenges of Rare Concurrent Intracranial Meningioma and Oligodendroglioma
• Differences in the prognostic role of age, extent of resection and tumor grade between astrocytoma IDHmt and oligodendroglioma: a single center cohort study
• Differential tractography and whole brain connectometry in primary motor area gliomas resection: A feasibility study
• Diffuse Gliomas with <em>FGFR3</em>::<em>TACC3</em> Fusion: Morphological and Molecular Features and Classification Challenges
• Diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters (DGONC), new name and new problems: an illustration of one case with atypical morphology and biology
• Diffuse Leptomeningeal Glioneuronal Tumor in Adults: Case Report and Literature Review
• Diffuse leptomeningeal glioneuronal tumor with distinct neuronal and glial components but identical diagnostic molecular and genetic features
• Enhanced Methodologies for Investigating the Electrophysiological Characteristics of Endogenous Pannexin 1 Intercellular Cell-Cell Channels
• Epigenetic dysregulation in cancers by isocitrate dehydrogenase 2 (IDH2)
• Expression of KCNN4 in adult-type diffuse gliomas and its correlations with clinicopathological features and patient prognosis
• Extracranial metastatic oligodendroglioma with molecular progression, case presentation
• Favorable Radiographic Response in a Patient With an Oligodendroglioma Treated With Azacitidine and Venetoclax for Acute Myeloid Leukemia
• Focused ultrasound blood-brain barrier disruption in high-grade gliomas: Scoping review of clinical studies
• Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma
• Genetically Distinct Oligosarcoma Arising from Oligodendroglioma: Systematic Review & Illustrative Case Example
• Genomic Alterations in Molecularly Defined Oligodendrogliomas
• Geriatric grade 2 and 3 gliomas: A national cancer database analysis of demographics, treatment utilization, and survival
• Glial fibrillary acidic protein, neurofilament light, matrix metalloprotease 3 and fatty acid binding protein 4 as non-invasive brain tumor biomarkers
• Glioma
• Glioma Type Prediction with Dynamic Contrast-Enhanced MR Imaging and Diffusion Kurtosis Imaging-A Standardized Multicenter Study
• Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022
• Grading of glioma tumors using digital holographic microscopy
• Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma
• Herpes Simplex Virus type 1 inhibits autophagy in glial cells but requires ATG5 for the success of viral replication
• High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma
• Higher YAP1 Levels Are Associated With Shorter Survival of Patients With Low Grade Astrocytoma
• Histone Acetyl Transferase 1 Is Overexpressed in Poor Prognosis, High-grade Meningeal and Glial Brain Cancers: Immunohistochemical and Aptahistochemical Study
• Histopathological Spectrum of Gliomas and Its Immunohistochemical Correlation in a Tertiary Care Setup
• IDH inhibition in gliomas: from preclinical models to clinical trials
• Immunohistochemical Expression of PTEN in Canine Gliomas
• Incidence and Survival of Patients With Malignant Primary Spinal Cord Tumors: A Population-Based Analysis
• Insights into brain tumor diagnosis: exploring <em>in situ</em> hybridization techniques
• Intra-axial Cortical-Based Tumour Presented as Homonymous Hemianopia in a Young Patient: A Diagnostic Dilemma
• Intraoperative mapping of epileptogenic foci and tumor infiltration in neuro-oncology patients with epilepsy
• Lomustine overdose in a patient with diffuse glioma: symptoms, management and outcome
• Long-term outcomes of CNS WHO grade 2 oligodendroglioma in adult patients: a single-institution experience
• Metastases and Primary Brain Tumors Affecting the Fornix of the Brain
• MGMT unmethylation and high levels of CD47 and TIGIT indicate a poor prognosis in adult diffuse gliomas
• Modular Hub Genes in DNA Microarray Suggest Potential Signaling Pathway Interconnectivity in Various Glioma Grades
• Molecular Pathology of Gliomas
• MRI Scoring Systems for Predicting Isocitrate Dehydrogenase Mutation and Chromosome 1p/19q Codeletion in Adult-type Diffuse Glioma Lacking Contrast Enhancement
• Multi-scale brain attributes contribute to the distribution of diffuse glioma subtypes
• Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma
• Non-hemorrhagic cerebellar contrast enhancement on intraoperative MRI during a supratentorial glioma resection: Concerning finding of no significance
• Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network
• Oligodendrocyte-specific expression of PSG8-AS1 suggests a role in myelination with prognostic value in oligodendroglioma
• Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy
• Oligodendroglioma: a neurological perspective in Sub-saharan Africa
• Perfusion percentage signal recovery and a mundane chicken wire: what could they have to do in oligodendrogliomas?
• Photodynamic therapy using talaporfin sodium for non-totally resectable malignant glioma
• Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Scoping Review of Case Reports and Case Series
• Primary spinal oligodendroglioma with intracranial extension: a case report
• Prognostic Impact of <em>TERT</em> Promoter Mutations in Adult-Type Diffuse Gliomas Based on WHO2021 Criteria
• PTBP1-mediated repression of neuron-specific CDC42 splicing constitutes a genomic alteration-independent, developmentally conserved vulnerability in IDH-wildtype glioblastoma
• Rare dual-genotype IDH mutant glioma: Review of previously reported cases and two new cases of true "oligoastrocytoma"
• Revisiting gliomatosis cerebri in adult-type diffuse gliomas: a comprehensive imaging, genomic and clinical analysis
• Revisiting oligodendroglioma grading in the 2021 WHO classification: calcification and larger contrast-enhancing tumor volume may predict higher oligodendroglioma grade
• Revisiting prognostic factors of gliomatosis cerebri in adult-type diffuse gliomas
• Rosettes and pseudorosettes in veterinary neuropathology
• Rostral cranial fossa and sinonasal neoplasms with cribriform plate involvement in 32 dogs and 17 cats
• SEOM-GEINO clinical guidelines for grade 2 gliomas (2023)
• Survival of Patients with Primary Brain Tumor: A Data Analysis of 10 Years
• Targeted radionuclide therapy for gliomas: emerging clinical trial landscape
• Targeting IDH1-Mutated Oligodendroglioma with Acid Ceramidase Inhibitors
• The biological significance of tumor grade, age, enhancement and extent of resection in IDH mutant gliomas: how should they inform treatment decision in the era of IDH inhibitors? Invited review
• The diagnostic challenge of lack of choline level elevation on 1H-MR spectroscopy in grade II-III gliomas
• The effect of resection of gliomas of the primary motor and sensory cortex on functional recovery and seizure outcome: A 10-year retrospective study
• The landscape of cancer-associated transcript fusions in adult brain tumors: a longitudinal assessment in 140 patients with cerebral gliomas and brain metastases
• The molecular signature and prognosis of glioma with preoperative intratumoral hemorrhage: a retrospective cohort analysis
• The relationships of platelet-derived growth factor, microvascular proliferation, and tumor cell proliferation in canine high-grade oligodendrogliomas: Immunohistochemistry of 45 tumors and an AFOB-01 xenograft mouse model
• Three-Dimensional Structure Light Robot-Assisted Frameless Stereotactic Brain Biopsy
• Ultra-high b-value DWI accurately identifies isocitrate dehydrogenase genotypes and tumor subtypes of adult-type diffuse gliomas
• Unilateral tactile agnosia as an onset symptom of corticobasal syndrome
• Unveiling hierarchy and spatial distribution of O⁶-methylguanine-DNA methyltransferase promoter methylation in World Health Organization grade 2-3 gliomas
• Updates on management of gliomas in the molecular age
• Use, access, and initial outcomes of off-label ivosidenib in patients with IDH1 mutant glioma
• Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign
• Using a three-dimensional-printed device with the patient's maxillary dental impression allows to perform minimally invasive brain biopsies in dogs and cats: a preliminary study
• Volumetric Response and Survival of Patients With Bulky IDH-Mutated Grade 3 Glioma Managed With FET-FDG-Guided Integrated Boost IMRT